Products for Research Use Only
RegisterLogin

LGD-6972

CAT: 0804-HY-12525-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-12525-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
LGD-6972 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research[1].
CAS Number
1207989-09-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
GCGR
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/LGD-6972.html
Purity
98.0
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NCCS(=O)(O)=O)C1=CC=C(C[C@H](C2=CC=C(C3=CC=C(C(C)(C)C)C=C3)C=C2)C(NC4=CC=C(C5=C(C)C=C(C)C=C5C)C=C4)=O)C=C1
Molecular Formula
C43H46N2O5S
Molecular Weight
702.90
Precautions
H302, H315, H319, H335
References & Citations
[1]Vajda EG, et al. Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus. Diabetes Obes Metab. 2017 Jan;19 (1) :24-32.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2

Related Products

CatalogName
HY-105318-01LGD-2226
HY-111309LGD-2941
HY-103576-01LGD-3303
HY-RI03672-01Mmu-miR-6972-3p inhibitor
HY-RI03673A-01Mmu-miR-6972-5p antagomir
HY-R03672A-01Mmu-miR-6972-3p agomir
HY-RI03673-01Mmu-miR-6972-5p inhibitor
HY-R03673-01Mmu-miR-6972-5p mimic
HY-R03672-01Mmu-miR-6972-3p mimic
HY-RI03672A-01Mmu-miR-6972-3p antagomir

Alternative Products

CatalogName
598783LGD-6972
A21840-25LGD-6972 25mg
T25711-01LGD-6972 sodium
A21840-100LGD-6972 100mg
A21840-50LGD-6972 50mg
A21840-5LGD-6972 5mg
GTR19274404-01LGD 6972 ammonium
A21840-10LGD-6972 10mg
A21840-1LGD-6972 1mg
A21840-10mM-DLGD-6972 10mM * 1mL in DMSO

Popular Products